(GUBRA) Gubra - Performance 27.6% in 12m
Compare GUBRA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
50.26%
#10 in Group
Rel. Strength
82.58%
#1394 in Universe
Total Return 12m
27.60%
#29 in Group
Total Return 5y
223.64%
#9 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -1.06%
65th Percentile in Group
12m Total Return: GUBRA (27.6%) vs XBI (-12.1%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-19.2% | 9.47% | 151% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
-11.7% | 23% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-1.45% | 26.1% | 39.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-10.9% | 9.64% | 39.3% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
| LONN SW Lonza |
-3.29% | 3.72% | 31.6% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
2.96% | 17.6% | 11.9% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-10.2% | -24.7% | -1.51% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-6.62% | 33.3% | -5.06% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: GUBRA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for GUBRA
| Total Return (including Dividends) | GUBRA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -32.32% | -14.90% | -7.04% |
| 3 Months | -47.80% | -14.51% | -10.88% |
| 12 Months | 27.60% | -12.11% | 5.72% |
| 5 Years | 223.64% | -20.56% | 100.77% |
| Trend Score (consistency of price movement) | GUBRA | XBI | S&P 500 |
| 1 Month | -91.5% | -85.2% | -76.1% |
| 3 Months | -84.6% | -87.6% | -86.4% |
| 12 Months | 39.6% | -24% | 67.8% |
| 5 Years | 90.6% | -52.8% | 84.3% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #167 | -20.5% | -27.2% |
| 3 Month | #161 | -38.9% | -41.4% |
| 12 Month | #28 | 45.2% | 20.7% |
| 5 Years | #14 | 225% | 145% |
FAQs
Does GUBRA Gubra outperforms the market?
Yes,
over the last 12 months GUBRA made 27.60%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.11%.
Over the last 3 months GUBRA made -47.80%, while XBI made -14.51%.
Over the last 3 months GUBRA made -47.80%, while XBI made -14.51%.
Performance Comparison GUBRA vs Indeces and Sectors
GUBRA vs. Indices GUBRA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.08% | -25.3% | -9.20% | 21.9% |
| US NASDAQ 100 | QQQ | 3.57% | -24.5% | -9.11% | 23.9% |
| US Dow Jones Industrial 30 | DIA | 1.18% | -27.2% | -11.2% | 20.9% |
| German DAX 40 | DAX | -9.42% | -24.3% | -27.8% | 8.32% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.92% | -24.6% | -14.1% | 19.7% |
| Hongkong Hang Seng | HSI | -4.59% | -21.2% | -10.6% | 11.5% |
| India NIFTY 50 | INDA | -0.93% | -35.7% | -8.62% | 26.9% |
| Brasil Bovespa | EWZ | -1.43% | -26.0% | -9.52% | 38.5% |
GUBRA vs. Sectors GUBRA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.27% | -24.7% | -17.4% | 14.3% |
| Consumer Discretionary | XLY | 4.67% | -26.1% | -11.4% | 20.3% |
| Consumer Staples | XLP | -2.18% | -32.2% | -16.9% | 15.1% |
| Energy | XLE | 2.12% | -20.4% | -8.14% | 40.4% |
| Financial | XLF | 0.37% | -27.5% | -17.1% | 8.24% |
| Health Care | XLV | 0.67% | -25.5% | -8.01% | 27.7% |
| Industrial | XLI | 0.58% | -26.4% | -8.57% | 23.7% |
| Materials | XLB | -0.42% | -24.9% | -1.78% | 35.5% |
| Real Estate | XLRE | -2.67% | -27.3% | -8.92% | 13.2% |
| Technology | XLK | 3.77% | -22.5% | -3.17% | 30.8% |
| Utilities | XLU | -2.44% | -30.2% | -13.4% | 1.21% |
| Aerospace & Defense | XAR | -1.58% | -31.7% | -18.6% | 4.44% |
| Biotech | XBI | -1.44% | -17.4% | 6.70% | 39.7% |
| Homebuilder | XHB | 3.69% | -23.1% | 10.2% | 39.3% |
| Retail | XRT | 3.32% | -26.6% | -1.91% | 34.6% |